Bayer’s strategic could potentially significantly reduce headwinds revolving around lawsuits stemming from Monsanto’s glyphosate-based weedkiller – Roundup. On Friday, shares of Bayer surged by 11% following a report from Bloomberg that it has proposed to pay $8 billion in order… Read More ›
cancer risks
Bayer faces strong legal headwinds, gains shareholders backing despite AGM rebuke
It would be interesting to see Bayer’s due diligence for its acquisition of Monsanto since even before Bayer’s $63 billion acquisition of Monsanto, the latter was facing lawsuits related to its Roundup weedkiller. According to two of Bayer’s largest German… Read More ›
Lawsuits from Monsanto’s weedkiller Roundup haunts Bayer
Bayer is likely to face negative investor sentiments on Friday at its AGM on the way its management team handled the $63 billion Monsanto deal. According to two sources familiar with the matter at hand, BlackRock will not support Bayer’s… Read More ›
Legal costs will determine whether Bayer AG would settle glyphosate related cases
According to one of the attorneys for the plaintiff, Bayer’s claims on glyphosate were “hypocritical beyond belief” given its own efforts to control the message on glyphosate, the most recent of which is a full-page advertisement in the Washington Post…. Read More ›